Colgate-Palmolive Company $CL Shares Sold by Armstrong Advisory Group Inc.

Key Points

• Armstrong Advisory Group Inc. significantly reduced its stake in Colgate-Palmolive by 94.9%, selling 6,730 shares and retaining only 359 shares worth $33,000.
• Colgate-Palmolive has recently declared a quarterly dividend of $0.52, with a yield of 2.6% and an upcoming payment date of November 14th.
• Analysts have mixed ratings on Colgate-Palmolive, with an average target price of $98.00 and ratings ranging from "Buy" to "Underweight."

Armstrong Advisory Group Inc. cut its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 94.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 359 shares of the company's stock after selling 6,730 shares during the period. Armstrong Advisory Group Inc.'s holdings in Colgate-Palmolive were worth $33,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of CL. Westend Capital Management LLC boosted its stake in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares during the period. Saudi Central Bank acquired a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $29,000. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $31,000. Finally, Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $33,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CL has been the subject of several research reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday, August 4th. Barclays lifted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Finally, Citigroup cut their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a report on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Price Performance

NYSE:CL opened at $80.11 on Wednesday. The firm has a market cap of $64.74 billion, a price-to-earnings ratio of 22.50, a price-to-earnings-growth ratio of 4.13 and a beta of 0.35. The company has a 50 day moving average price of $84.62 and a 200-day moving average price of $88.99. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1-year low of $78.76 and a 1-year high of $104.49.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.91 EPS. Equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's payout ratio is presently 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.